Julika Ribbat-Idel

12PUBLICATIONS
49CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 07, 2026
ADC Target Profiling in NSCLC: Generalizable AI Separates TROP-2 and cMET Phenotypes.

Philipp Anders, Marvin Sextro, Katja Lingelbach

|Apr 14, 2025
Prognostic Value of SOX2 and NANOG Expression in Recurrent Oral Squamous Cell Carcinoma.

Mohamed Falougy, Clara Taubitz, Mohab Ragab

|Mar 29, 2023
TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC.

Amelie von Bernuth, Julika Ribbat-Idel, Luise Klapper

|Jun 24, 2022
TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC.

Luise Klapper, Christian Idel, Patrick Kuppler

|Jun 24, 2022
Increased Abundances of CD16+ Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4+ T Cell Disturbances in Oropharyngeal Cancer.

Christian Idel, Christina Polasky, Julika Ribbat-Idel

|May 14, 2022
Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma.

Justus Bottner, Julika Ribbat-Idel, Luise Klapper

Pageof 2

Frequent Collaborators

4 joint publications

Christian Watermann

2 joint publications

Helen Pasternack

2 joint publications

Johannes Brägelmann

2 joint publications

Patrick Kuppler